MarketPulse — Real-Time Financial News & Market Analysis

Latest News

8,629 articles
Tue, Mar 24
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Zalos Lands $3.6M to Deploy AI Agents in Enterprise Finance Systems

Zalos raises $3.6M seed round led by 14 Peaks to scale AI agents automating finance workflows across legacy ERP systems without replacements or integrations.
ORCLORCLpDSAPAI automationseed funding
BenzingaBenzinga··Namrata Sen

Huang's Extreme Co-Design Playbook: How NVIDIA's CEO Scales Leadership Without One-On-Ones

NVIDIA CEO Jensen Huang explains his extreme co-design strategy and why he avoids traditional one-on-one meetings with 60 direct reports, favoring collaborative problem-solving instead.
NVDAMETAextreme co-designleadership strategy
BenzingaBenzinga··Akanksha Bakshi

Yimutian Stock Soars 22% on Strategic Funding, Share Buyback, and Acquisition

$YMT surges 22% on $30M funding, $3M buyback, and digital commerce acquisition. 2026 revenue target set at 1 billion yuan.
YMTacquisitionrevenue guidance
BenzingaBenzinga··Prnewswire

Alfa Laval Sets Q1 2026 Earnings Release; Conference Call Scheduled for April 22

Alfa Laval will release Q1 2026 earnings April 22, 2026, followed by investor conference call hosted by CEO Tom Erixon and CFO Fredrik Ekström.
ALFVYconference callQ1 earnings
The Motley FoolThe Motley Fool··Neil Patel

PayPal's Lost Decade: How $1,000 Investment Grew Just 12% While S&P 500 Soared 282%

PayPal's $1,000 investment grew just 12% in a decade versus S&P 500's 282%, reflecting slowing 4% revenue growth amid intense competition despite commanding $1.8 trillion in payment volume.
PYPLfintechrevenue growth
BenzingaBenzinga··Prnewswire

IceCure Medical Bolsters Leadership Team with CFO, Medical Director Appointments

IceCure Medical ($ICCM) names Meir Peleg as CFO and appoints Dr. Richard Fine as Medical Director, capitalizing on ProSense® cryoablation system's FDA clearance momentum.
ICCMbreast cancerleadership
BenzingaBenzinga··Not Specified

ECGI to Acquire RezyFi for $25M, Combining Mortgage Tech with Tokenization

ECGI Holdings acquires RezyFi for $25M in preferred stock, integrating $140M annual mortgage funding platform across 29 states with tokenization capabilities.
ECGIacquisitionfintech
The Motley FoolThe Motley Fool··Lawrence Rothman, Cfa

FMC Stock Faces Uphill Battle to Reach $15 Amid Revenue Slump

FMC stock faces steep odds reaching $15 amid 5% revenue declines and weak profitability; strategic options being explored.
FMCacquisitionvaluation
BenzingaBenzinga··Prnewswire

RMX Industries Appoints VStock Transfer as New Transfer Agent

RMX Industries appoints VStock Transfer as new transfer agent, enhancing shareholder services and administrative infrastructure for the OTCQB-listed technology company.
RMXIOTCQBtransfer agent
The Motley FoolThe Motley Fool··Dominic Basulto

Ark Invest Dismisses Bitcoin Quantum Threat as Overblown Fear-Mongering

Ark Invest's Cathie Wood dismisses quantum computing threats to Bitcoin as overstated, arguing quantum computers remain years away and post-quantum solutions are already in development.
JEFpost-quantum cryptographyquantum threat
BenzingaBenzinga··Prnewswire

Aethlon Medical Advances Hemopurifier Trial to Final Cohort After Safety Clearance

Aethlon Medical's Hemopurifier device advances to final clinical trial phase following positive safety review with no adverse events reported.
AEMDclinical trialoncology
BenzingaBenzinga··Prnewswire

Braemar Hotels Declares Monthly Preferred Dividends Across Four Series for March 2026

Braemar Hotels declares monthly preferred dividends across four series, payable April 15, 2026, maintaining returns to preferred shareholders.
BHRBHRpBBHRpDdividend declarationREIT
BenzingaBenzinga··Michael Kern

Pentagon's 2027 Chinese Rare Earth Ban Sparks U.S. Supply Chain Race

Pentagon rare earth ban by 2027 forces U.S. supply chain overhaul as China dominates critical processing capabilities essential for defense systems.
MPUSARCRMLCRMLWLYSDY+2supply chainnational security
BenzingaBenzinga··Prnewswire

Corvex Executes 35.8% Stock Dividend as AI Computing Merger Closes

Corvex ($MOVE) distributes 35.8% special stock dividend to shareholders March 30, 2026, following merger agreement. AI infrastructure platform raises $40.2M.
MOVEmergerGPU infrastructure
BenzingaBenzinga··Prnewswire

Leatt Corp Posts 41% Revenue Surge to $61.9M as Helmet Sales Soar 59%

Leatt Corporation reported 41% revenue growth to $61.9M and 248% net income surge to $3.26M in 2025, marking its sixth consecutive quarterly growth with strength across all product categories.
LEATQ4 2025 earningsrevenue growth
BenzingaBenzinga··Prnewswire

Hyperscale Data's Bitcoin Treasury Exceeds Market Cap as Company Doubles Down on Crypto Strategy

Hyperscale Data ($GPUS) holds 627.9 Bitcoin worth $42.6M, with combined cash and crypto assets representing 147% of market cap.
GPUSGPUSpDBitcoin treasurymarket capitalization
GlobeNewswire Inc.GlobeNewswire Inc.··Holzer & Holzer, Llc

Four Companies Face Shareholder Lawsuits Over Alleged Disclosure Failures

Law firm Holzer & Holzer announces April 6, 2026 lead plaintiff deadlines for class actions against TCPC, MREO, POM, and RARE over alleged material misstatements.
TCPCMREORAREPOMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Holzer & Holzer, Llc

Shareholder Lawsuits Mount Against Kyndryl, uniQure as Lead Plaintiff Deadlines Loom

Shareholder lawsuits target Kyndryl and uniQure with lead plaintiff deadlines approaching April 2026. Investors must act quickly to join litigation.
KDBRBRMETCMETCBMETCI+5investor losseslead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Holzer & Holzer, Llc

Legal Battle Heats Up: Major Shareholder Suits Filed Against $BRBR, $BYND, and $METC

Three shareholder lawsuits filed against $BRBR, $BYND, and $METC over alleged sales misstatements, asset valuations, and mine development disclosures. Lead plaintiff deadlines announced; affected investors encouraged to seek legal representation.
BRBRMETCMETCBMETCIMETCZ+1investor losseslead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Na

IMUNON Sets March 31 Call to Detail 2025 Results, OVATION 3 Trial Progress

$IMNN to discuss 2025 results and OVATION 3 Phase 3 trial progress for IMNN-001 ovarian cancer immunotherapy on March 31, 2026.
IMNNPhase 3 clinical trialfinancial results